Patents by Inventor Zengguang Wang

Zengguang Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240150243
    Abstract: It discloses a sustained release grouting material, a preparation method and an application thereof; the sustained release grouting material comprises a water swelling core and a water-soluble sustained release coating, the water swelling core is composed of bentonite, SAP and xanthan gum, which is granulated by disc granulator relying on the cohesiveness of xanthan gum; the water-soluble sustained-release coating is prepared by mixing water-soluble starch, polyvinyl alcohol, poloxamer, lubricant and plasticizer with deionized water to obtain a film-forming solution, and the film-forming solution is coated on a coating machine; the invention uses a coating machine to coat a layer of slow-release coating on the surface of the water-absorbing expansion core, and adjusts the coating thickness by controlling the mass ratio of the coating film-forming liquid to the water-absorbing expansion core particles, so as to realize the controllable water absorption onset time of the expansion core.
    Type: Application
    Filed: November 6, 2023
    Publication date: May 9, 2024
    Applicant: SHANDONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
    Inventors: Lihua Wang, Chunfeng Li, Zhijie Wen, Zengguang Pang, Xiaoming Fan, Qinghua Shu, Shifu Sun, Qingbiao Wang, Chunquan Dai, Weiwei Han, Shunrong Wang
  • Publication number: 20240068159
    Abstract: A compact steel cord is provided. The cord includes a core-filament I steel wire with a diameter of d0, and four middle-layer M steel wires with a diameter of d1 and eight outer-layer O steel wires with a diameter of d2 that are twisted around the core-filament I steel wire in the same lay direction and the same lay length. Gaps L are reserved between the outer-layer O steel wires, an average width of the gaps L is not smaller than 0.02 mm, and the total size of the gaps L is larger than d0 and smaller than d1. The steel cord of a stable structure can be obtained by controlling the proportion of the sizes of all layers of monofilaments, the rubber coating performance of a tire cord can also be improved, the corrosion resistance, fatigue resistance, impact resistance and adhesion retention of a tire are improved.
    Type: Application
    Filed: May 20, 2021
    Publication date: February 29, 2024
    Applicant: Jiangsu Xingda Steel Tyre Cord Co., Ltd.
    Inventors: Xiang LIU, Aiping WANG, Weiming MA, Nianpeng ZHAO, Xianghui LIU, Zengguang KE, Hengxiang CAO
  • Patent number: 11574207
    Abstract: Techniques are described for training and evaluating a proximal factorization machine engine. In one or more embodiments, the engine receives a set of training data that identifies a set of actions taken by a plurality of users with respect to a plurality of items. The engine generates, for a prediction model, (a) a first set of model parameters representing relationships between features of the plurality of users and the set of actions, and (b) a second set of model parameters representing interactions between different features of the plurality of users and the plurality of items. For each respective item in a plurality of items, the engine computes a probabilistic score based on the model parameters. The engine selects and presents a subset of items based on the probabilistic scores.
    Type: Grant
    Filed: September 15, 2017
    Date of Patent: February 7, 2023
    Assignee: Oracle International Corporation
    Inventors: Michael Edward Pearmain, Janet Barbara Barnes, David John Dewsnip, Zengguang Wang
  • Patent number: 11542719
    Abstract: The present invention discloses a flexible connecting structure of a prefabricated component and a building main body. The flexible connecting structure comprises multiple layers of cast-in-situ building main bodies spaced up and down, a prefabricated component is connected between two adjacent cast-in-situ building main bodies, a tenon is provided at the lower end of the prefabricated component, a mortise matching the tenon is provided on the top surface of the cast-in-situ building main body, and the prefabricated component is socketed to the lower layer of cast-in-situ building main body by tenon-and-mortise cooperation; and a first flexible layer for reducing the connection rigidity between the prefabricated component and the upper layer of cast-in-situ building main body is provided at the junction between the prefabricated component and the upper layer of cast-in-situ building main body.
    Type: Grant
    Filed: May 26, 2020
    Date of Patent: January 3, 2023
    Assignees: HUNAN CONSTRUCTION ENGINEERING GROUP CO., LTD., HUNAN CONSTRUCTION TECHNOLOGY RESEARCH INSTITUTE
    Inventors: Hao Chen, Weichao Chen, Weijun Tang, Mingliang Zhang, Qingfeng Dai, Tuo Shi, Zengguang Wang, Qinglian Yuan, Wei Liu
  • Publication number: 20200378145
    Abstract: The present invention discloses a flexible connecting structure of a prefabricated component and a building main body. The flexible connecting structure comprises multiple layers of cast-in-situ building main bodies spaced up and down, a prefabricated component is connected between two adjacent cast-in-situ building main bodies, a tenon is provided at the lower end of the prefabricated component, a mortise matching the tenon is provided on the top surface of the cast-in-situ building main body, and the prefabricated component is socketed to the lower layer of cast-in-situ building main body by tenon-and-mortise cooperation; and a first flexible layer for reducing the connection rigidity between the prefabricated component and the upper layer of cast-in-situ building main body is provided at the junction between the prefabricated component and the upper layer of cast-in-situ building main body.
    Type: Application
    Filed: May 26, 2020
    Publication date: December 3, 2020
    Inventors: Hao CHEN, Weichao CHEN, Weijun TANG, Mingliang ZHANG, Qingfeng DAI, Tuo SHI, Zengguang WANG, Qinglian YUAN, Wei LIU
  • Publication number: 20180082191
    Abstract: Techniques are described for training and evaluating a proximal factorization machine engine. In one or more embodiments, the engine receives a set of training data that identifies a set of actions taken by a plurality of users with respect to a plurality of items. The engine generates, for a prediction model, (a) a first set of model parameters representing relationships between features of the plurality of users and the set of actions, and (b) a second set of model parameters representing interactions between different features of the plurality of users and the plurality of items. For each respective item in a plurality of items, the engine computes a probabilistic score based on the model parameters. The engine selects and presents a subset of items based on the probabilistic scores.
    Type: Application
    Filed: September 15, 2017
    Publication date: March 22, 2018
    Applicant: Oracle International Corporation
    Inventors: Michael Edward Pearmain, Janet Barnes, David John Dewsnip, Zengguang Wang
  • Patent number: 8454972
    Abstract: The present disclosure provides compositions for eliciting an immune response, including a prophylactic immune response, against human immunodeficiency virus. The composition includes nucleic acid constructs encoding HIV antigenic polypeptides of multiple clades or strains. Methods for eliciting an immune response by administering the composition to a subject are also provided.
    Type: Grant
    Filed: January 20, 2011
    Date of Patent: June 4, 2013
    Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Services, GenVec, Inc.
    Inventors: Gary J. Nabel, Ling Xu, Bimal Chakrabarti, Lan Wu, Zhi-yong Yang, Jason G. D. Gall, C. Richter King, Zengguang Wang
  • Patent number: 8323961
    Abstract: The invention provides a composition comprising four adenoviral vectors, each comprising a nucleic acid sequence encoding a clade A HIV Env protein, a clade B HIV Env protein, a clade C HIV Env protein, and a clade B HIV Gag-Pol fusion protein, respectively. The invention also provides a method of inducing an immune response against HIV-1 in an animal comprising administering the composition to the animal.
    Type: Grant
    Filed: April 14, 2011
    Date of Patent: December 4, 2012
    Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Services, GenVex, Inc.
    Inventors: Gary J. Nabel, Bimal Chakrabarti, Wing-Pui Kong, Yue Huang, Zengguang Wang, legal representative, Zhi-Yong Yang, Jason G. D. Gall, C. Richter King
  • Publication number: 20110274721
    Abstract: In one embodiment, the invention provides a multiclade HIV plasmid DNA or viral vector vaccine including components from different clades of Env (optionally Env chimeras) and Gag-Pol-(optionally)Nef from a singlr clade. The vaccine of the invention may further include V1, V2, V3, or V4 deletions or combinations thereof. In another embodiment, the invention provides multiclade HIV envelope immunogens.
    Type: Application
    Filed: April 14, 2011
    Publication date: November 10, 2011
    Applicants: GenVec, Inc., The U.S.A., as represented by the Secretary, Department of Health and Human Services
    Inventors: Gary J. Nabel, Bimal Chakrabarti, Wing-Pui Kong, Yue Huang, Zengguang Wang, Zhi-Yong Yang, Jason G.D. Gall, C. Richter King
  • Publication number: 20110200636
    Abstract: The present disclosure provides compositions for eliciting an immune response, including a prophylactic immune response, against human immunodeficiency virus. The composition includes nucleic acid constructs encoding HIV antigenic polypeptides of multiple clades or strains. Methods for eliciting an immune response by administering the composition to a subject are also provided.
    Type: Application
    Filed: January 20, 2011
    Publication date: August 18, 2011
    Applicants: The USA, as represented by the Secretary, Dept. of Health and Human Services, GenVec, Inc.
    Inventors: Gary J. Nabel, Yue Huang, Zengguang Wang, Ling Xu, Bimal Chakrabarti, Lan Wu, Zhi-yong Yang, Jason G.D. Gall, C. Richter King
  • Patent number: 7947822
    Abstract: The invention provides a composition comprising a pharmaceutically acceptable carrier and six plasmids, each of which encodes an HIV Env, Gag, Pol, or Nef protein. The invention also provides a method of inducing an immune response in an animal using the composition.
    Type: Grant
    Filed: January 7, 2010
    Date of Patent: May 24, 2011
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Gary J. Nabel, Bimal Chakrabarti, Wing-Pui Kong, Yue Huang, Zengguang Wang, legal representative, Zhi-Yong Yang
  • Publication number: 20100111998
    Abstract: In one embodiment, the invention provides a multiclade HIV plasmid DNA or viral vector vaccine including components from different clades of Env (optionally Env chimeras) and Gag-Pol-(optionally)Nef from a single Glade. The vaccine of the invention may further include V1, V2, V3, or V4 deletions or combinations thereof. In another embodiment, the invention provides multiclade HIV envelope immunogens.
    Type: Application
    Filed: January 7, 2010
    Publication date: May 6, 2010
    Applicants: Service
    Inventors: Gary J. Nabel, Bimal Chakrabarti, Wing-pui Kong, Yue Huang, Zengguang Wang, Zhi-yong Yang
  • Patent number: 7666427
    Abstract: In one embodiment, the invention provides a multiclade HIV plasmid DNA or viral vector vaccine including components from different clades of Env (optionally Env chimeras) and Gag-Pol-(optionally)Nef from a single clade. The vaccine of the invention may further include V1, V2, V3, or V4 deletions or combinations thereof. In another embodiment, the invention provides multiclade HIV envelope immunogens.
    Type: Grant
    Filed: June 13, 2007
    Date of Patent: February 23, 2010
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Gary J. Nabel, Bimal Chakrabarti, Wing-pui Kong, Yue Huang, Zengguang Wang, legal representative, Zhi-yong Yang
  • Publication number: 20090214588
    Abstract: The present disclosure provides compositions for eliciting an immune response, including a prophylactic immune response, against human immunodeficiency virus. The composition includes nucleic acid constructs encoding HIV antigenic polypeptides of multiple clades or strains. Methods for eliciting an immune response by administering the composition to a subject are also provided.
    Type: Application
    Filed: July 15, 2005
    Publication date: August 27, 2009
    Inventors: Gary J. Nabel, Yue Huang, Zengguang Wang, Ling Xu, Bimal Chakrabarti, Lan Wu, Zhi-yong Yang, Jason G.D. Gall, C. Richter King
  • Publication number: 20090175910
    Abstract: Modified HIV Env, Gag, Pol, or Nef DNA with improved ability to elicit antibody and CTL responses to HIV antigens have been identified as prototype immunogens for the treatment and prevention of HIV infections.
    Type: Application
    Filed: November 10, 2008
    Publication date: July 9, 2009
    Inventors: Gary J. Nabel, Bimal K. Chakrabarti, Yue Huang, Zengguang Wang
  • Publication number: 20080286306
    Abstract: In one embodiment, the invention provides a multiclade HIV plasmid DNA or viral vector vaccine including components from different clades of Env (optionally Env chimeras) and Gag-Pol-(optionally)Nef from a single clade. The vaccine of the invention may further include V1, V2, V3, or V4 deletions or combinations thereof. In another embodiment, the invention provides multiclade HIV envelope immunogens.
    Type: Application
    Filed: June 13, 2007
    Publication date: November 20, 2008
    Inventors: Gary J. Nabel, Bimal Chakrabarti, Wing-pui Kong, Yue Huang, Zhi-yong Yang, Zengguang Wang
  • Publication number: 20060275897
    Abstract: In one embodiment, the invention provides a multiclade HIV plasmid DNA or viral vector vaccine including components from different clades of Env (optionally Env chimeras) and Gag-Pol-(optionally)Nef from a singlr clade. The vaccine of the invention may further include V1, V2, V3, or V4 deletions or combinations thereof. In another embodiment, the invention provides multiclade HIV envelope immunogens.
    Type: Application
    Filed: March 15, 2006
    Publication date: December 7, 2006
    Inventors: Gary Nabel, Bimal Chakrabarti, Wing-pui Kong, Yue Huang, Zengguang Wang, Zhi-yong Yang